相关实验视频

Updated: Jun 1, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

探索CX3CR1作为肉瘤的预后生物标志物和免疫治疗点

Tengfei Li¹, Xun Li², Pengcheng Kang²

¹The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Translational oncology

|January 21, 2025

概括

化基因受体CX3CR1在肉瘤 (SARC) 中升高,并与更好的生存相关. 针对其翻译后修改 (PTM) 为SARC患者提供了新的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

瘤 (SARC) 是一种具有不良结果的侵袭性癌症.
CX3CR1,一种化学因受体,在SARC进展和免疫反应中发挥作用.
翻译后修改 (PTMs) 调节了癌症中的CX3CR1功能.

研究的目的:

调查CX3CR1表达,功能和在SARC中的预后意义.
在SARC背景下探索PTMs在CX3CR1活动中的作用.
评估CX3CR1作为SARC的潜在治疗点.

主要方法:

对CX3CR1表达,甲基化和免疫透的TCGA数据的分析.
通过CRISPR查,评估CX3CR1在瘤生长中的作用.
在体外实验 (敲击/过度表达,CCK-8,流细胞计) 来研究CX3CR1功能和亡.

主要成果:

在SARC组织中增加CX3CR1表达与改善的生存结果相关.
通过CX3CR1甲基化模式,可以将瘤与正常组织区分开来.
克里斯普尔查证实了CX3CR1在瘤生长中的重要作用;PTM稳定了CX3CR1,增强了信号传输.
在体外,CX3CR1调制影响了炎症和亡反应.

结论:

CX3CR1是肉瘤的潜在预后生物标志物.
准CX3CR1及其PTMs为SARC提供了一个有前途的治疗策略.
专注于CX3CR1的个性化治疗方法可以改善患者的治疗结果.

关键词:

生物标志物生物标志物在CX3CR1中,基因表达基因表达免疫治疗是一种免疫疗法.甲基化甲基化甲基化预测预测预测预测肉瘤肉瘤是一种肉瘤.

更多相关视频

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...